Granahan Investment Management, LLC Agios Pharmaceuticals, Inc. Transaction History

Granahan Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$24.53 - $35.75 $2.21 Million - $3.23 Million	-90,222 Reduced 68.29%	41,886 $1.39 Million
Q1 2025 May 15, 2025	BUY	$29.3 - $35.9 $481,135 - $589,513	16,421 Added 14.19%	132,108 $3.87 Million
Q4 2024 Feb 14, 2025	SELL	$32.86 - $61.64 $1.15 Million - $2.16 Million	-35,098 Reduced 23.28%	115,687 $3.8 Million
Q3 2024 Nov 14, 2024	BUY	$41.19 - $49.72 $574,476 - $693,444	13,947 Added 10.19%	150,785 $6.7 Million
Q2 2024 Aug 14, 2024	BUY	$27.55 - $48.83 $3.77 Million - $6.68 Million	136,838 New	136,838 $5.9 Million

256

63.8M

2.06M

911K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.39B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.